Nipah Virus Impairs Autocrine IFN Signaling by Sequestering STAT1 and STAT2 into Inclusion Bodies

Viruses. 2023 Feb 17;15(2):554. doi: 10.3390/v15020554.

Abstract

Nipah virus (NiV) is an emerging zoonotic paramyxovirus that causes fatal infections in humans. As with most disease-causing viruses, the pathogenic potential of NiV is linked to its ability to block antiviral responses, e.g., by antagonizing IFN signaling through blocking STAT proteins. One of the STAT1/2-binding proteins of NiV is the phosphoprotein (P), but its functional role in IFN antagonism in a full viral context is not well defined. As NiV P is required for genome replication and specifically accumulates in cytosolic inclusion bodies (IBs) of infected cells, we hypothesized that this compartmentalization might play a role in P-mediated IFN antagonism. Supporting this notion, we show here that NiV can inhibit IFN-dependent antiviral signaling via a NiV P-dependent sequestration of STAT1 and STAT2 into viral IBs. Consequently, the phosphorylation/activation and nuclear translocation of STAT proteins in response to IFN is limited, as indicated by the lack of nuclear pSTAT in NiV-infected cells. Blocking autocrine IFN signaling by sequestering STAT proteins in IBs is a not yet described mechanism by which NiV could block antiviral gene expression and provides the first evidence that cytosolic NiV IBs may play a functional role in IFN antagonism.

Keywords: IFN; Nipah virus; STAT1; STAT2; autocrine signaling; inclusions; phosphoprotein.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antiviral Agents
  • Cytosol
  • Humans
  • Inclusion Bodies, Viral*
  • Interferons / metabolism
  • Nipah Virus*
  • STAT1 Transcription Factor
  • STAT2 Transcription Factor

Substances

  • Antiviral Agents
  • Interferons
  • STAT1 protein, human
  • STAT1 Transcription Factor
  • STAT2 protein, human
  • STAT2 Transcription Factor

Grants and funding

This research was funded by the Deutsche Forschungsgemeinschaft (DFG, German Research Foundation) to A.M. (Projektnummer 197785619—SFB 1021).